{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-003733","form_type":"8-K","ticker":"PMI","cik":"0002030617","company_name":"Picard Medical, Inc.","filed_at":"2026-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.411915+00:00","generated_at":"2026-05-15T04:56:56.592862+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Picard Medical Q1 preliminary revenue up 79.9% to $1.1M; driven by STAH sales","bullets":["Preliminary unaudited revenue of $1.1M for Q1 2026 vs $0.6M in Q1 2025, a 79.9% increase.","Growth driven by higher SynCardia Total Artificial Heart (STAH) sales, favorable U.S. reimbursement, and pricing adjustments on driver rentals.","CEO cites progress in commercial initiatives and increased STAH utilization as bridge-to-transplant.","Full Q1 results to be filed in Form 10-Q on or before May 15, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-003733","json":"https://secwatch.observer/filing/0001829126-26-003733.json","markdown":"https://secwatch.observer/filing/0001829126-26-003733.md","text":"https://secwatch.observer/filing/0001829126-26-003733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626003733/0001829126-26-003733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626003733/picardmedical_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:56:56.592862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e5ed7e18a5ebe58e4a9031e1d8cc05335319f9df","claim":"Picard Medical, Inc. reported first quarter ended March 31, 2026 results: revenue $1.1 million.","evidence_excerpt":"Revenue rose 79.9% to $1.1 million for the three months ended March 31, 2026, from $0.6 million for the three months ended March 31, 2025","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626003733/0001829126-26-003733-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$1.1 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}